Key takeaways Blue Cross Blue Shield may or may not cover Wegovy
If that were what you got from your doctor, would you want to bring it up
Compared to placebo (3.3%, 3.2 kg), patients lost a mean of 13.4% (13.5 kg) of body weight in the 10 mg group and 15.7% (15.6 kg) of body weight in the 15 mg group
Key Reasons for the Ban: Lack of scientific and therapeutic rationale for combination use No added clinical benefit over individual drug therapy Increased risk of adverse drug reactions and drug interactions Potential contribution to antimicrobial resistance (in antibiotic combinations) Overall unnecessary burden on patients and healthcare systems Regulatory Action: The ban reflects Indias strengthened approach toward evidence-based medicine and rational drug use, ensuring that only safe, effective, and clinically justified drug combinations remain in the market
All these eventually help with diabetes management
People who trained through their GLP-1 cycle have more muscle, a higher resting metabolic rate, and established habits
